nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—Increased Diuresis—Hydrochlorothiazide—nephrolithiasis	0.795	1	CiPCiCtD
Amiloride—Fatigability—Hydrochlorothiazide—nephrolithiasis	0.0154	0.245	CcSEcCtD
Amiloride—SLC9A1—nephron—nephrolithiasis	0.00669	0.138	CbGeAlD
Amiloride—Serum potassium increased—Hydrochlorothiazide—nephrolithiasis	0.00641	0.102	CcSEcCtD
Amiloride—PLAU—nephron—nephrolithiasis	0.00634	0.131	CbGeAlD
Amiloride—Blood potassium increased—Hydrochlorothiazide—nephrolithiasis	0.00308	0.0489	CcSEcCtD
Amiloride—SLC22A2—nephron—nephrolithiasis	0.003	0.0617	CbGeAlD
Amiloride—Atrioventricular block complete—Hydrochlorothiazide—nephrolithiasis	0.00266	0.0422	CcSEcCtD
Amiloride—ASIC2—Stimuli-sensing channels—CLCN4—nephrolithiasis	0.00265	0.0282	CbGpPWpGaD
Amiloride—ASIC2—Stimuli-sensing channels—CLCN5—nephrolithiasis	0.00265	0.0282	CbGpPWpGaD
Amiloride—Intraocular pressure increased—Hydrochlorothiazide—nephrolithiasis	0.00211	0.0335	CcSEcCtD
Amiloride—SCNN1G—Stimuli-sensing channels—CLCN4—nephrolithiasis	0.00201	0.0214	CbGpPWpGaD
Amiloride—SCNN1D—Stimuli-sensing channels—CLCN4—nephrolithiasis	0.00201	0.0214	CbGpPWpGaD
Amiloride—SCNN1B—Stimuli-sensing channels—CLCN5—nephrolithiasis	0.00201	0.0214	CbGpPWpGaD
Amiloride—SCNN1D—Stimuli-sensing channels—CLCN5—nephrolithiasis	0.00201	0.0214	CbGpPWpGaD
Amiloride—ASIC1—Stimuli-sensing channels—CLCN4—nephrolithiasis	0.00201	0.0214	CbGpPWpGaD
Amiloride—SCNN1A—Stimuli-sensing channels—CLCN4—nephrolithiasis	0.00201	0.0214	CbGpPWpGaD
Amiloride—SCNN1B—Stimuli-sensing channels—CLCN4—nephrolithiasis	0.00201	0.0214	CbGpPWpGaD
Amiloride—SCNN1G—Stimuli-sensing channels—CLCN5—nephrolithiasis	0.00201	0.0214	CbGpPWpGaD
Amiloride—ASIC1—Stimuli-sensing channels—CLCN5—nephrolithiasis	0.00201	0.0214	CbGpPWpGaD
Amiloride—SCNN1A—Stimuli-sensing channels—CLCN5—nephrolithiasis	0.00201	0.0214	CbGpPWpGaD
Amiloride—SLC22A4—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.00184	0.0196	CbGpPWpGaD
Amiloride—ASIC2—Ion channel transport—CLCN5—nephrolithiasis	0.00173	0.0184	CbGpPWpGaD
Amiloride—ASIC2—Ion channel transport—CLCN4—nephrolithiasis	0.00173	0.0184	CbGpPWpGaD
Amiloride—AOC1—nephron tubule—nephrolithiasis	0.00151	0.031	CbGeAlD
Amiloride—Encephalopathy—Hydrochlorothiazide—nephrolithiasis	0.00145	0.023	CcSEcCtD
Amiloride—SLC9A1—nephron tubule—nephrolithiasis	0.00144	0.0297	CbGeAlD
Amiloride—SCNN1G—renal system—nephrolithiasis	0.0014	0.0287	CbGeAlD
Amiloride—Peptic ulcer—Hydrochlorothiazide—nephrolithiasis	0.00139	0.0221	CcSEcCtD
Amiloride—AOC1—renal system—nephrolithiasis	0.00137	0.0282	CbGeAlD
Amiloride—PLAU—nephron tubule—nephrolithiasis	0.00137	0.0282	CbGeAlD
Amiloride—Heartburn—Hydrochlorothiazide—nephrolithiasis	0.00135	0.0214	CcSEcCtD
Amiloride—SCNN1G—kidney—nephrolithiasis	0.00135	0.0278	CbGeAlD
Amiloride—AOC1—kidney—nephrolithiasis	0.00132	0.0273	CbGeAlD
Amiloride—SCNN1G—cortex of kidney—nephrolithiasis	0.00131	0.0271	CbGeAlD
Amiloride—SLC9A1—renal system—nephrolithiasis	0.00131	0.027	CbGeAlD
Amiloride—SCNN1A—Ion channel transport—CLCN4—nephrolithiasis	0.00131	0.014	CbGpPWpGaD
Amiloride—SCNN1G—Ion channel transport—CLCN4—nephrolithiasis	0.00131	0.014	CbGpPWpGaD
Amiloride—ASIC1—Ion channel transport—CLCN4—nephrolithiasis	0.00131	0.014	CbGpPWpGaD
Amiloride—SCNN1B—Ion channel transport—CLCN4—nephrolithiasis	0.00131	0.014	CbGpPWpGaD
Amiloride—SCNN1D—Ion channel transport—CLCN5—nephrolithiasis	0.00131	0.014	CbGpPWpGaD
Amiloride—SCNN1B—Ion channel transport—CLCN5—nephrolithiasis	0.00131	0.014	CbGpPWpGaD
Amiloride—ASIC1—Ion channel transport—CLCN5—nephrolithiasis	0.00131	0.014	CbGpPWpGaD
Amiloride—SCNN1G—Ion channel transport—CLCN5—nephrolithiasis	0.00131	0.014	CbGpPWpGaD
Amiloride—SCNN1A—Ion channel transport—CLCN5—nephrolithiasis	0.00131	0.014	CbGpPWpGaD
Amiloride—SCNN1D—Ion channel transport—CLCN4—nephrolithiasis	0.00131	0.014	CbGpPWpGaD
Amiloride—AOC1—cortex of kidney—nephrolithiasis	0.00129	0.0266	CbGeAlD
Amiloride—SLC9A1—kidney—nephrolithiasis	0.00127	0.0261	CbGeAlD
Amiloride—PLAU—renal system—nephrolithiasis	0.00124	0.0256	CbGeAlD
Amiloride—SLC9A1—cortex of kidney—nephrolithiasis	0.00124	0.0254	CbGeAlD
Amiloride—PLAU—kidney—nephrolithiasis	0.0012	0.0248	CbGeAlD
Amiloride—SCNN1A—nephron tubule—nephrolithiasis	0.0012	0.0247	CbGeAlD
Amiloride—SLC9A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A6—nephrolithiasis	0.00118	0.0126	CbGpPWpGaD
Amiloride—SCNN1B—renal system—nephrolithiasis	0.00118	0.0243	CbGeAlD
Amiloride—PLAU—cortex of kidney—nephrolithiasis	0.00117	0.0241	CbGeAlD
Amiloride—SCNN1B—kidney—nephrolithiasis	0.00114	0.0235	CbGeAlD
Amiloride—SCNN1B—cortex of kidney—nephrolithiasis	0.00111	0.0229	CbGeAlD
Amiloride—SCNN1A—renal system—nephrolithiasis	0.00109	0.0224	CbGeAlD
Amiloride—SLC9A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC3A1—nephrolithiasis	0.00108	0.0115	CbGpPWpGaD
Amiloride—SLC9A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A3—nephrolithiasis	0.00108	0.0115	CbGpPWpGaD
Amiloride—SCNN1A—kidney—nephrolithiasis	0.00105	0.0217	CbGeAlD
Amiloride—SCNN1A—cortex of kidney—nephrolithiasis	0.00103	0.0211	CbGeAlD
Amiloride—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.001	0.0159	CcSEcCtD
Amiloride—PLAU—Osteopontin Signaling—SPP1—nephrolithiasis	0.000996	0.0106	CbGpPWpGaD
Amiloride—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.000947	0.015	CcSEcCtD
Amiloride—SLC9A1—Osteoclast Signaling—SPP1—nephrolithiasis	0.000936	0.00997	CbGpPWpGaD
Amiloride—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.000913	0.0145	CcSEcCtD
Amiloride—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.000873	0.0139	CcSEcCtD
Amiloride—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.000869	0.00926	CbGpPWpGaD
Amiloride—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.000841	0.0133	CcSEcCtD
Amiloride—SLC9A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A1—nephrolithiasis	0.000818	0.00871	CbGpPWpGaD
Amiloride—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.00081	0.00863	CbGpPWpGaD
Amiloride—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.000769	0.0122	CcSEcCtD
Amiloride—SLC9A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A1—nephrolithiasis	0.00076	0.0081	CbGpPWpGaD
Amiloride—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.000741	0.0118	CcSEcCtD
Amiloride—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.000728	0.0115	CcSEcCtD
Amiloride—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.000712	0.0113	CcSEcCtD
Amiloride—Thirst—Hydrochlorothiazide—nephrolithiasis	0.000709	0.0113	CcSEcCtD
Amiloride—SLC9A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A9—nephrolithiasis	0.000678	0.00722	CbGpPWpGaD
Amiloride—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.000678	0.0108	CcSEcCtD
Amiloride—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.000675	0.0107	CcSEcCtD
Amiloride—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.000675	0.0107	CcSEcCtD
Amiloride—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.000669	0.0106	CcSEcCtD
Amiloride—SLC22A2—nephron tubule—nephrolithiasis	0.000647	0.0133	CbGeAlD
Amiloride—SLC9A1—Defective B3GAT3 causes JDSSDHD—SLC26A1—nephrolithiasis	0.000635	0.00676	CbGpPWpGaD
Amiloride—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.000616	0.00978	CcSEcCtD
Amiloride—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.000608	0.00964	CcSEcCtD
Amiloride—ASIC2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000602	0.00641	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000602	0.00641	CbGpPWpGaD
Amiloride—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.000595	0.00945	CcSEcCtD
Amiloride—SLC22A2—renal system—nephrolithiasis	0.000588	0.0121	CbGeAlD
Amiloride—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.000587	0.00932	CcSEcCtD
Amiloride—SLC22A2—kidney—nephrolithiasis	0.000569	0.0117	CbGeAlD
Amiloride—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.000568	0.00902	CcSEcCtD
Amiloride—PLAU—Endochondral Ossification—PTH—nephrolithiasis	0.000555	0.00591	CbGpPWpGaD
Amiloride—SLC22A2—cortex of kidney—nephrolithiasis	0.000554	0.0114	CbGeAlD
Amiloride—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.000545	0.00866	CcSEcCtD
Amiloride—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.000545	0.00866	CcSEcCtD
Amiloride—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.000539	0.00855	CcSEcCtD
Amiloride—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.000537	0.00853	CcSEcCtD
Amiloride—ASIC2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000536	0.00571	CbGpPWpGaD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.000527	0.00562	CbGpPWpGaD
Amiloride—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.000507	0.00804	CcSEcCtD
Amiloride—PLAU—Osteopontin-mediated events—SPP1—nephrolithiasis	0.000497	0.0053	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000491	0.00523	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000491	0.00523	CbGpPWpGaD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.000482	0.00514	CbGpPWpGaD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.000482	0.00514	CbGpPWpGaD
Amiloride—SLC22A4—nephron tubule—nephrolithiasis	0.00048	0.00989	CbGeAlD
Amiloride—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.000475	0.00754	CcSEcCtD
Amiloride—SCNN1A—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000456	0.00486	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000456	0.00486	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000456	0.00486	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000456	0.00486	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000456	0.00486	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000456	0.00486	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000456	0.00486	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000456	0.00486	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000456	0.00486	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000456	0.00486	CbGpPWpGaD
Amiloride—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00045	0.00714	CcSEcCtD
Amiloride—SLC22A4—renal system—nephrolithiasis	0.000436	0.00899	CbGeAlD
Amiloride—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.000435	0.00691	CcSEcCtD
Amiloride—SLC22A4—kidney—nephrolithiasis	0.000422	0.00869	CbGeAlD
Amiloride—SLC22A1—renal system—nephrolithiasis	0.000416	0.00856	CbGeAlD
Amiloride—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.000413	0.00655	CcSEcCtD
Amiloride—SLC22A4—cortex of kidney—nephrolithiasis	0.000411	0.00846	CbGeAlD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000406	0.00433	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000406	0.00433	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000406	0.00433	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000406	0.00433	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000406	0.00433	CbGpPWpGaD
Amiloride—SLC22A1—kidney—nephrolithiasis	0.000402	0.00827	CbGeAlD
Amiloride—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.0004	0.00636	CcSEcCtD
Amiloride—Tension—Hydrochlorothiazide—nephrolithiasis	0.000399	0.00633	CcSEcCtD
Amiloride—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.000395	0.00626	CcSEcCtD
Amiloride—Back pain—Hydrochlorothiazide—nephrolithiasis	0.000393	0.00624	CcSEcCtD
Amiloride—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.000391	0.0062	CcSEcCtD
Amiloride—PLAU—Beta3 integrin cell surface interactions—SPP1—nephrolithiasis	0.000383	0.00408	CbGpPWpGaD
Amiloride—Tremor—Hydrochlorothiazide—nephrolithiasis	0.000381	0.00604	CcSEcCtD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000372	0.00396	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000372	0.00396	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000372	0.00396	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000372	0.00396	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000372	0.00396	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000372	0.00396	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000372	0.00396	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000372	0.00396	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000372	0.00396	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000372	0.00396	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000372	0.00396	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000372	0.00396	CbGpPWpGaD
Amiloride—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.000368	0.00392	CbGpPWpGaD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.000366	0.00389	CbGpPWpGaD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.000366	0.00389	CbGpPWpGaD
Amiloride—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.000365	0.00579	CcSEcCtD
Amiloride—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.000359	0.0057	CcSEcCtD
Amiloride—Cough—Hydrochlorothiazide—nephrolithiasis	0.000355	0.00563	CcSEcCtD
Amiloride—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.000346	0.00549	CcSEcCtD
Amiloride—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.000346	0.00549	CcSEcCtD
Amiloride—ASIC2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000346	0.00368	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000346	0.00368	CbGpPWpGaD
Amiloride—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.000342	0.00365	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000342	0.00364	CbGpPWpGaD
Amiloride—SLC9A1—Carbohydrate metabolism—SLC26A1—nephrolithiasis	0.000341	0.00363	CbGpPWpGaD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00034	0.00362	CbGpPWpGaD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00034	0.00362	CbGpPWpGaD
Amiloride—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.000334	0.00531	CcSEcCtD
Amiloride—Shock—Hydrochlorothiazide—nephrolithiasis	0.000326	0.00518	CcSEcCtD
Amiloride—PLAU—FGF signaling pathway—SPP1—nephrolithiasis	0.000319	0.0034	CbGpPWpGaD
Amiloride—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.000316	0.00502	CcSEcCtD
Amiloride—ASIC2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000308	0.00328	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000308	0.00328	CbGpPWpGaD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000303	0.00323	CbGpPWpGaD
Amiloride—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.000302	0.0048	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000301	0.0032	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000301	0.0032	CbGpPWpGaD
Amiloride—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.0003	0.00476	CcSEcCtD
Amiloride—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.000298	0.00473	CcSEcCtD
Amiloride—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.000296	0.00469	CcSEcCtD
Amiloride—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000295	0.00468	CcSEcCtD
Amiloride—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.000292	0.00463	CcSEcCtD
Amiloride—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.000288	0.00458	CcSEcCtD
Amiloride—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.000286	0.00454	CcSEcCtD
Amiloride—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000284	0.0045	CcSEcCtD
Amiloride—Pain—Hydrochlorothiazide—nephrolithiasis	0.000284	0.0045	CcSEcCtD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000282	0.003	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000282	0.003	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000282	0.003	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000282	0.003	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000282	0.003	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000282	0.003	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000282	0.003	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000282	0.003	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000282	0.003	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000282	0.003	CbGpPWpGaD
Amiloride—PLAU—Endochondral Ossification—SPP1—nephrolithiasis	0.000278	0.00297	CbGpPWpGaD
Amiloride—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000273	0.00434	CcSEcCtD
Amiloride—PLAU—Beta1 integrin cell surface interactions—SPP1—nephrolithiasis	0.000272	0.00289	CbGpPWpGaD
Amiloride—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.000271	0.0043	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000268	0.00285	CbGpPWpGaD
Amiloride—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000262	0.00416	CcSEcCtD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000262	0.00279	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000262	0.00279	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000262	0.00279	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000262	0.00279	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000262	0.00279	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000262	0.00279	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000262	0.00279	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000262	0.00279	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000262	0.00279	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000262	0.00279	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000246	0.00262	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000245	0.00261	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000245	0.00261	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.000241	0.00257	CbGpPWpGaD
Amiloride—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000238	0.00378	CcSEcCtD
Amiloride—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000235	0.00372	CcSEcCtD
Amiloride—SCNN1D—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000233	0.00249	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000233	0.00249	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000233	0.00249	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000233	0.00249	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000233	0.00249	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000233	0.00249	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000233	0.00249	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000233	0.00249	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000233	0.00249	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000233	0.00249	CbGpPWpGaD
Amiloride—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000227	0.0036	CcSEcCtD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.000221	0.00235	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.000221	0.00235	CbGpPWpGaD
Amiloride—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000219	0.00348	CcSEcCtD
Amiloride—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000211	0.00335	CcSEcCtD
Amiloride—Rash—Hydrochlorothiazide—nephrolithiasis	0.000209	0.00332	CcSEcCtD
Amiloride—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000209	0.00332	CcSEcCtD
Amiloride—Headache—Hydrochlorothiazide—nephrolithiasis	0.000208	0.0033	CcSEcCtD
Amiloride—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000197	0.00313	CcSEcCtD
Amiloride—SCNN1A—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000187	0.00199	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000187	0.00199	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000187	0.00199	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000187	0.00199	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000187	0.00199	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000186	0.00198	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000186	0.00198	CbGpPWpGaD
Amiloride—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.000174	0.00185	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000173	0.00184	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000173	0.00184	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.000167	0.00178	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.000167	0.00178	CbGpPWpGaD
Amiloride—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.000162	0.00173	CbGpPWpGaD
Amiloride—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.000162	0.00172	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—SLC7A9—nephrolithiasis	0.00016	0.00171	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—DGKH—nephrolithiasis	0.00016	0.00171	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000156	0.00166	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000156	0.00166	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000154	0.00164	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000154	0.00164	CbGpPWpGaD
Amiloride—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.000151	0.00161	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000139	0.00148	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000138	0.00147	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000138	0.00147	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000123	0.00131	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000123	0.00131	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.000114	0.00122	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000112	0.00119	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000112	0.00119	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GRHPR—nephrolithiasis	0.000107	0.00114	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.000106	0.00113	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.000104	0.00111	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.000104	0.00111	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	9.73e-05	0.00104	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	9.73e-05	0.00104	CbGpPWpGaD
Amiloride—SLC9A1—Disease—SLC26A1—nephrolithiasis	9.66e-05	0.00103	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—AGXT—nephrolithiasis	9.51e-05	0.00101	CbGpPWpGaD
Amiloride—SLC9A1—Disease—ATP6V0A4—nephrolithiasis	8.61e-05	0.000917	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	8.5e-05	0.000905	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	8.5e-05	0.000905	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—APRT—nephrolithiasis	8.09e-05	0.000862	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—SLC26A1—nephrolithiasis	8.09e-05	0.000862	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	7.91e-05	0.000843	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	7.91e-05	0.000843	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	7.9e-05	0.000842	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	7.9e-05	0.000842	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	7.37e-05	0.000785	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	7.37e-05	0.000785	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	7.36e-05	0.000783	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	7.36e-05	0.000783	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	7.04e-05	0.00075	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	7.04e-05	0.00075	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	6.86e-05	0.00073	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	6.86e-05	0.00073	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	6.56e-05	0.000698	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	6.51e-05	0.000693	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	6.51e-05	0.000693	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	6.11e-05	0.000651	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	6.07e-05	0.000646	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	6.07e-05	0.000646	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	5.8e-05	0.000618	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—AQP1—nephrolithiasis	5.76e-05	0.000614	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—AQP1—nephrolithiasis	5.63e-05	0.0006	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	5.41e-05	0.000576	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	5.31e-05	0.000565	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	5.31e-05	0.000565	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CHRM3—nephrolithiasis	5.21e-05	0.000555	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	4.94e-05	0.000527	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	4.94e-05	0.000527	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	4.02e-05	0.000428	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	4.02e-05	0.000428	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	3.75e-05	0.000399	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	3.75e-05	0.000399	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	3.74e-05	0.000398	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	3.74e-05	0.000398	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	3.48e-05	0.000371	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	3.48e-05	0.000371	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	3.33e-05	0.000355	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	3.33e-05	0.000355	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	3.11e-05	0.000331	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	3.11e-05	0.000331	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	2.66e-05	0.000284	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	2.48e-05	0.000264	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GRHPR—nephrolithiasis	2.31e-05	0.000246	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GRHPR—nephrolithiasis	2.15e-05	0.000229	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AGXT—nephrolithiasis	2.06e-05	0.000219	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AGXT—nephrolithiasis	1.92e-05	0.000204	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC26A1—nephrolithiasis	1.75e-05	0.000186	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—APRT—nephrolithiasis	1.75e-05	0.000186	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC26A1—nephrolithiasis	1.63e-05	0.000174	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—APRT—nephrolithiasis	1.63e-05	0.000174	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AQP1—nephrolithiasis	1.25e-05	0.000133	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AQP1—nephrolithiasis	1.16e-05	0.000124	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CHRM3—nephrolithiasis	1.13e-05	0.00012	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CHRM3—nephrolithiasis	1.05e-05	0.000112	CbGpPWpGaD
